In Response to Current Global Supply Disruption
Ed Hamdeh • May 13, 2022
kbDNA has ready-to-ship products in North America
Disruptions in Asia are weighing on the global supply chain. In the U.S, the effects can be felt all across research laboratories, especially in bioscience sectors. Whether it's equipment, consumables or specialty reagents; everyone seems to be waiting on overdue products and ambiguous delivery dates.
As domestic providers, we offer more flexibility to help resolve immediate laboratory needs. Contact us at kbDNA for general product inquiries.
Products Include:
Research Chemicals
Reagents | Analyte Products
Kits | Assays
Labware | Consumables
If you are experiencing order delays...
Send us a brief description of your product needs. We will get back to you with pricing & lead time!
Ask us
Discover kbDNA’s rapid workflow for repurifying rituximab biosimilars to high-purity standards—featuring SEC overlays, gel schematics, and SOPs.
Unfiltered truths, hidden risks, and real data behind life sciences R&D in North America. Discover the facts nobody else is sharing—read the full report now
This article explores the complexities of biosimilars, including their development process, regulatory challenges, economic impact, and future prospects. It highlights the potential of biosimilars to reduce healthcare costs and increase patient access to biologic therapies, providing valuable insights for biopharmaceutical and academic researchers.
